Conditions: Ovarian Cancer
Keywords: Serous, Ovarian cancer, PARP, BRCA1, BRCA2, Poly(ADP ribose) polymerases, Platinum sensitive, Homologous Recombination Deficiency (HRD)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 265
Healthy volunteers: no

Brief summary:
The primary purpose of this study to determine if AZD2281 is effective and well tolerated in maintaining the improvement in your cancer after previous platinum-based chemotherapy

Detailed description:

Arms:
arm 1: AZD2281 arm 2: matching placebo

Interventions: intervention 1: AZD2281 intervention 2: matching placebo
Intervention descriptions: intervention 1: Tablets Oral BID intervention 2: matching placebo bid

Protocol document: